GLAUKOS CORP
NYSE: GKOS (Glaukos Corporation)
Kemas kini terakhir: 2 jam lalu97.60
0.00 (0.00%)
| Penutupan Terdahulu | 97.60 |
| Buka | 96.21 |
| Jumlah Dagangan | 797,572 |
| Purata Dagangan (3B) | 981,826 |
| Modal Pasaran | 5,576,912,896 |
| Harga / Jualan (P/S) | 13.15 |
| Harga / Buku (P/B) | 7.30 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Jul 2025 - 4 Aug 2025 |
| Margin Keuntungan | -30.57% |
| Margin Operasi (TTM) | -19.39% |
| EPS Cair (TTM) | -2.27 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 24.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 14.09% |
| Nisbah Semasa (MRQ) | 6.49 |
| Aliran Tunai Operasi (OCF TTM) | -45.97 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -17.66 M |
| Pulangan Atas Aset (ROA TTM) | -6.68% |
| Pulangan Atas Ekuiti (ROE TTM) | -20.36% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Menurun | Bercampur |
| Medical Devices (Global) | Menurun | Bercampur | |
| Stok | Glaukos Corporation | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 4.5 |
| Purata Bergerak Teknikal | 5.0 |
| Osilator Teknikal | 2.0 |
| Purata | 2.75 |
|
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 3.28% |
| % Dimiliki oleh Institusi | 101.66% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Wellington Management Group Llp | 31 Mar 2025 | 2,290,790 |
| Ameriprise Financial Inc | 31 Mar 2025 | 1,943,955 |
| Invesco Ltd. | 31 Mar 2025 | 1,452,116 |
| Brown Capital Management Llc | 31 Mar 2025 | 1,192,589 |
| Westfield Capital Management Co Lp | 31 Mar 2025 | 1,084,184 |
| Driehaus Capital Management Llc | 31 Mar 2025 | 973,625 |
| Janus Henderson Group Plc | 31 Mar 2025 | 900,367 |
| Gilder Gagnon Howe & Co Llc | 31 Mar 2025 | 836,529 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 175.00 (Mizuho, 79.30%) | Beli |
| Median | 115.00 (17.83%) | |
| Rendah | 72.00 (Morgan Stanley, -26.23%) | Jual |
| Purata | 122.25 (25.26%) | |
| Jumlah | 6 Beli, 1 Pegang, 1 Jual | |
| Harga Purata @ Panggilan | 86.54 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Morgan Stanley | 06 May 2025 | 72.00 (-26.23%) | Jual | 87.20 |
| Stephens & Co. | 02 May 2025 | 115.00 (17.83%) | Beli | 87.61 |
| Needham | 01 May 2025 | 115.00 (17.83%) | Beli | 83.54 |
| Stifel | 01 May 2025 | 115.00 (17.83%) | Beli | 83.54 |
| Truist Securities | 01 May 2025 | 135.00 (38.32%) | Beli | 83.54 |
| 11 Apr 2025 | 140.00 (43.44%) | Beli | 90.07 | |
| Wells Fargo | 01 May 2025 | 86.00 (-11.89%) | Pegang | 83.54 |
| Mizuho | 16 Apr 2025 | 175.00 (79.30%) | Beli | 88.80 |
| Piper Sandler | 15 Apr 2025 | 165.00 (69.06%) | Beli | 94.52 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 13 May 2025 | Pengumuman | Glaukos Announces Participation in Upcoming Investor Conferences |
| 30 Apr 2025 | Pengumuman | Glaukos Announces First Quarter 2025 Financial Results |
| 23 Apr 2025 | Pengumuman | Glaukos to Present Multiple Scientific Abstracts at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting |
| 16 Apr 2025 | Pengumuman | Glaukos Announces the Release of its 2024 Sustainability Report |
| 09 Apr 2025 | Pengumuman | Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |